Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Apr. 03, 2021 | Apr. 20, 2021 | |
Document and Entity Information | ||
Entity Registrant Name | SILICON LABORATORIES INC. | |
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Apr. 3, 2021 | |
Document Transition Report | false | |
Entity File Number | 000-29823 | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 74-2793174 | |
Entity Address, Address Line One | 400 West Cesar Chavez | |
Entity Address, City or Town | Austin | |
Entity Address, State or Province | TX | |
Entity Address, Postal Zip Code | 78701 | |
City Area Code | 512 | |
Local Phone Number | 416-8500 | |
Title of 12(b) Security | Common Stock, $0.0001 par value | |
Trading Symbol | SLAB | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 44,748,946 | |
Entity Central Index Key | 0001038074 | |
Current Fiscal Year End Date | --01-01 | |
Document Fiscal Year Focus | 2021 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Apr. 03, 2021 | Jan. 02, 2021 |
Current assets: | ||
Cash and cash equivalents | $ 205,224 | $ 202,720 |
Short-term investments | 367,708 | 521,963 |
Accounts receivable, net | 103,699 | 95,169 |
Inventories | 79,244 | 66,662 |
Prepaid expenses and other current assets | 105,056 | 89,307 |
Total current assets | 860,931 | 975,821 |
Property and equipment, net | 141,000 | 139,439 |
Goodwill | 631,932 | 631,932 |
Other intangible assets, net | 154,379 | 166,084 |
Other assets, net | 82,381 | 80,211 |
Total assets | 1,870,623 | 1,993,487 |
Current liabilities: | ||
Accounts payable | 68,998 | 54,949 |
Current portion of convertible debt, net | 134,480 | |
Deferred revenue and returns liability | 13,450 | 12,986 |
Other current liabilities | 68,351 | 82,083 |
Total current liabilities | 150,799 | 284,498 |
Convertible debt, net | 434,288 | 428,945 |
Other non-current liabilities | 78,557 | 80,203 |
Total liabilities | 663,644 | 793,646 |
Commitments and contingencies | ||
Stockholders' equity: | ||
Preferred stock - $0.0001 par value; 10,000 shares authorized; no shares issued | ||
Common stock - $0.0001 par value; 250,000 shares authorized; 44,749 and 43,925 shares issued and outstanding at April 3, 2021 and January 2, 2021, respectively | 4 | 4 |
Additional paid-in capital | 199,576 | 204,359 |
Retained earnings | 1,007,173 | 993,664 |
Accumulated other comprehensive income | 226 | 1,814 |
Total stockholders' equity | 1,206,979 | 1,199,841 |
Total liabilities and stockholders' equity | $ 1,870,623 | $ 1,993,487 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares shares in Thousands | Apr. 03, 2021 | Jan. 02, 2021 |
Condensed Consolidated Balance Sheets | ||
Preferred stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized | 10,000 | 10,000 |
Preferred stock, shares issued | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 250,000 | 250,000 |
Common stock, shares issued | 44,749 | 43,925 |
Common stock, shares outstanding | 44,749 | 43,925 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
Apr. 03, 2021 | Apr. 04, 2020 | |
Condensed Consolidated Statements of Income | ||
Revenues | $ 255,505 | $ 214,877 |
Cost of revenues | 104,922 | 85,711 |
Gross profit | 150,583 | 129,166 |
Operating expenses: | ||
Research and development | 76,474 | 71,223 |
Selling, general and administrative | 51,950 | 53,996 |
Operating expenses | 128,424 | 125,219 |
Operating income | 22,159 | 3,947 |
Other income (expense): | ||
Interest income and other, net | 2,875 | 3,251 |
Interest expense | (11,324) | (5,541) |
Income before income taxes | 13,710 | 1,657 |
Provision (benefit) for income taxes | 201 | (587) |
Net income | $ 13,509 | $ 2,244 |
Earnings per share: | ||
Basic (in dollars per share) | $ 0.31 | $ 0.05 |
Diluted (in dollars per share) | $ 0.29 | $ 0.05 |
Weighted-average common shares outstanding: | ||
Basic (in shares) | 44,160 | 43,642 |
Diluted (in shares) | 45,832 | 44,388 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands | 3 Months Ended | |
Apr. 03, 2021 | Apr. 04, 2020 | |
Condensed Consolidated Statements of Comprehensive Income | ||
Net income | $ 13,509 | $ 2,244 |
Net changes to available-for-sale securities: | ||
Unrealized losses arising during the period | (836) | (469) |
Reclassification for gains included in net income | (358) | (100) |
Net changes to cash flow hedges: | ||
Unrealized losses arising during the period | (657) | (809) |
Reclassification for (gains) losses included in net income | (159) | 141 |
Other comprehensive loss, before tax | (2,010) | (1,237) |
Provision (benefit) for income taxes | (422) | (260) |
Other comprehensive loss | (1,588) | (977) |
Comprehensive income | $ 11,921 | $ 1,267 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands | Common Stock | Additional Paid-In Capital | Retained EarningsCumulative effect of adoption of accounting standard | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Cumulative effect of adoption of accounting standard | Total |
Balance at Dec. 28, 2019 | $ 4 | $ 133,793 | $ 525 | $ 980,608 | $ 646 | $ 525 | $ 1,115,051 |
Balance (in shares) at Dec. 28, 2019 | 43,496 | ||||||
Increase (Decrease) in Stockholders' Equity | |||||||
Net income | 2,244 | 2,244 | |||||
Other comprehensive loss | (977) | (977) | |||||
Stock issuances, net of shares withheld for taxes | (16,294) | (16,294) | |||||
Stock issuances, net of shares withheld for taxes (in shares) | 384 | ||||||
Repurchases of common stock | (16,287) | (16,287) | |||||
Repurchases of common stock (in shares) | (210) | ||||||
Stock-based compensation | 15,341 | 15,341 | |||||
Balance at Apr. 04, 2020 | $ 4 | 116,553 | 983,377 | (331) | 1,099,603 | ||
Balance (in shares) at Apr. 04, 2020 | 43,670 | ||||||
Balance at Jan. 02, 2021 | $ 4 | 204,359 | 993,664 | 1,814 | $ 1,199,841 | ||
Balance (in shares) at Jan. 02, 2021 | 43,925 | 43,925 | |||||
Increase (Decrease) in Stockholders' Equity | |||||||
Net income | 13,509 | $ 13,509 | |||||
Other comprehensive loss | (1,588) | (1,588) | |||||
Stock issuances, net of shares withheld for taxes | (17,817) | (17,817) | |||||
Stock issuances, net of shares withheld for taxes (in shares) | 296 | ||||||
Stock-based compensation | 13,782 | 13,782 | |||||
Convertible debt activity | (748) | (748) | |||||
Convertible debt activity (in shares) | 528 | ||||||
Balance at Apr. 03, 2021 | $ 4 | $ 199,576 | $ 1,007,173 | $ 226 | $ 1,206,979 | ||
Balance (in shares) at Apr. 03, 2021 | 44,749 | 44,749 |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 3 Months Ended | |
Apr. 03, 2021 | Apr. 04, 2020 | |
Operating Activities | ||
Net income | $ 13,509 | $ 2,244 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation of property and equipment | 4,529 | 4,183 |
Amortization of other intangible assets and other assets | 11,705 | 9,827 |
Amortization of debt discount and debt issuance costs | 6,456 | 3,736 |
Loss on extinguishment of convertible debt | 3,370 | |
Stock-based compensation expense | 13,826 | 15,313 |
Deferred income taxes | (3,197) | (2,364) |
Changes in operating assets and liabilities: | ||
Accounts receivable | (8,530) | 1,542 |
Inventories | (12,626) | 4,777 |
Prepaid expenses and other assets | (13,621) | 23,576 |
Accounts payable | 14,116 | 2,748 |
Other current liabilities and income taxes | (13,429) | (9,134) |
Deferred revenue and returns liability | 464 | 4,114 |
Other non-current liabilities | (2,066) | (862) |
Net cash provided by operating activities | 14,506 | 59,700 |
Investing Activities | ||
Purchases of marketable securities | (8,251) | (70,910) |
Sales and maturities of marketable securities | 161,392 | 126,920 |
Purchases of property and equipment | (6,176) | (4,135) |
Purchases of other assets | (578) | (370) |
Net cash provided by investing activities | 146,387 | 51,505 |
Financing Activities | ||
Proceeds from revolving line of credit | 310,000 | |
Payments on debt | (140,572) | |
Repurchases of common stock | (16,287) | |
Payment of taxes withheld for vested stock awards | (17,817) | (16,294) |
Net cash provided by (used in) financing activities | (158,389) | 277,419 |
Increase in cash and cash equivalents | 2,504 | 388,624 |
Cash and cash equivalents at beginning of period | 202,720 | 227,146 |
Cash and cash equivalents at end of period | $ 205,224 | $ 615,770 |
Significant Accounting Policies
Significant Accounting Policies | 3 Months Ended |
Apr. 03, 2021 | |
Significant Accounting Policies | |
Significant Accounting Policies | 1. Significant Accounting Policies Basis of Presentation and Principles of Consolidation The Condensed Consolidated Financial Statements included herein are unaudited; however, they contain all normal recurring accruals and adjustments which, in the opinion of management, are necessary to present fairly the condensed consolidated financial position of Silicon Laboratories Inc. and its subsidiaries (collectively, the “Company”) at April 3, 2021 and January 2, 2021, the condensed consolidated results of its operations for the three months ended April 3, 2021 and April 4, 2020, the Condensed Consolidated Statements of Comprehensive Income for the three months ended April 3, 2021 and April 4, 2020, the Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three months ended April 3, 2021 and April 4, 2020, and the Condensed Consolidated Statements of Cash Flows for the three months ended April 3, 2021 and April 4, 2020. All intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated results of operations for the three months ended April 3, 2021 are not necessarily indicative of the results to be expected for the full year. The accompanying unaudited Condensed Consolidated Financial Statements do not include certain footnotes and financial presentations normally required under U.S. generally accepted accounting principles (GAAP). Therefore, these Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto for the year ended January 2, 2021, included in the Company’s Form 10-K filed with the Securities and Exchange Commission (SEC) on February 3, 2021. The Company prepares financial statements on a 52- or 53-week fiscal year that ends on the Saturday closest to December 31. Fiscal 2021 will have 52 weeks. Fiscal 2020 had 53 weeks with the extra week occurring in the first quarter of the year. In a 52-week year, each fiscal quarter consists of 13 weeks. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Among the significant estimates affecting the financial statements are those related to inventories, goodwill, acquired intangible assets, other long-lived assets, revenue recognition, stock-based compensation and income taxes. Actual results could differ from those estimates, and such differences could be material to the financial statements. Revenue Recognition Revenue is recognized when control of the promised goods or services is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Substantially all of the Company’s contracts with customers contain a single performance obligation, the sale of mixed-signal integrated circuit (IC) products. This performance obligation is satisfied when control of the product is transferred to the customer, which typically occurs upon delivery. Unsatisfied performance obligations primarily represent contracts for products with future delivery dates. The Company has opted to not disclose the amount of unsatisfied performance obligations as these contracts have original expected durations of less than one year. The transaction price reflects the Company’s expectations about the consideration it will be entitled to receive from the customer and may include fixed or variable amounts. Variable consideration primarily includes sales made to distributors under agreements allowing certain rights of return, referred to as stock rotation, and credits issued to the distributor due to price protection. The Company estimates variable consideration at the most likely amount to which it expects to be entitled. The estimate is based on information available to the Company, including recent sales activity and pricing data. The Company applies a constraint to its variable consideration estimate which considers both the likelihood of a return and the amount of a potential price concession. Variable consideration that does not meet revenue recognition criteria is deferred. The Company records a right of return asset in prepaid expenses and other current assets for the costs of distributor inventory not meeting revenue recognition criteria. A corresponding deferred revenue and returns liability amount is recorded for unrecognized revenue associated with such costs. The Company’s products carry a one-year replacement warranty. Payments are typically due within 30 days of invoicing and do not include a significant financing component. 1. Significant Accounting Policies (Continued) Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40) |
Earnings Per Share
Earnings Per Share | 3 Months Ended |
Apr. 03, 2021 | |
Earnings Per Share | |
Earnings Per Share | 2. Earnings Per Share The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data): Three Months Ended April 3, April 4, 2021 2020 Net income $ 13,509 $ 2,244 Shares used in computing basic earnings per share 44,160 43,642 Effect of dilutive securities: Stock-based awards and convertible debt 1,672 746 Shares used in computing diluted earnings per share 45,832 44,388 Earnings per share: Basic $ 0.31 $ 0.05 Diluted $ 0.29 $ 0.05 The Company intends to settle the principal amount of its convertible senior notes in cash and any excess value in shares in the event of a conversion. Accordingly, shares issuable upon conversion of the principal amount have been excluded from the calculation of diluted earnings per share. If the market value of the notes under certain prescribed conditions exceeds the conversion amount, the excess is included in the denominator for the computation of diluted earnings per share using the treasury stock method. For the three months ended April 3, 2021 and April 4, 2020, approximately 1.1 million and 0.3 million shares, respectively, were included in the denominator for the calculation of diluted earnings per share. See Note 6, Debt |
Fair Value of Financial Instrum
Fair Value of Financial Instruments | 3 Months Ended |
Apr. 03, 2021 | |
Fair Value of Financial Instruments | |
Fair Value of Financial Instruments | 3. Fair Value of Financial Instruments The fair values of the Company’s financial instruments are recorded using a hierarchical disclosure framework based upon the level of subjectivity of the inputs used in measuring assets and liabilities. The three levels are described below: Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date. 3. Fair Value of Financial Instruments (Continued) Level 2 – Inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 – Inputs are unobservable for the asset or liability and are developed based on the best information available in the circumstances, which might include the Company’s own data. The following summarizes the valuation of the Company’s financial instruments (in thousands). The tables do not include either cash on hand or assets and liabilities that are measured at historical cost or any basis other than fair value. Fair Value Measurements at April 3, 2021 Using Quoted Prices in Significant Other Significant Active Markets for Observable Unobservable Identical Assets Inputs Inputs Description (Level 1) (Level 2) (Level 3) Total Assets: Cash equivalents: Money market funds $ 67,279 $ — $ — $ 67,279 Corporate debt securities — 1,202 — 1,202 Total cash equivalents $ 67,279 $ 1,202 $ — $ 68,481 Short-term investments: Government debt securities $ 5,226 $ 80,124 $ — $ 85,350 Corporate debt securities — 282,358 — 282,358 Total short-term investments $ 5,226 $ 362,482 $ — $ 367,708 Other assets, net: Auction rate securities $ — $ — $ 5,262 $ 5,262 Total $ — $ — $ 5,262 $ 5,262 Total $ 72,505 $ 363,684 $ 5,262 $ 441,451 Fair Value Measurements at January 2, 2021 Using Quoted Prices in Significant Other Significant Active Markets for Observable Unobservable Identical Assets Inputs Inputs Description (Level 1) (Level 2) (Level 3) Total Assets: Cash equivalents: Money market funds $ 75,606 $ — $ — $ 75,606 Corporate debt securities — 14,995 — 14,995 Government debt securities 2,355 2,564 — 4,919 Total cash equivalents $ 77,961 $ 17,559 $ — $ 95,520 Short-term investments: Government debt securities $ 38,461 $ 104,112 $ — $ 142,573 Corporate debt securities — 379,390 — 379,390 Total short-term investments $ 38,461 $ 483,502 $ — $ 521,963 Other assets, net: Auction rate securities $ — $ — $ 5,340 $ 5,340 Total $ — $ — $ 5,340 $ 5,340 Total $ 116,422 $ 501,061 $ 5,340 $ 622,823 3. Fair Value of Financial Instruments (Continued) Valuation methodology The Company’s cash equivalents and short-term investments that are classified as Level 2 are valued using non-binding market consensus prices that are corroborated with observable market data; quoted market prices for similar instruments in active markets; or pricing models, such as a discounted cash flow model, with all significant inputs derived from or corroborated with observable market data. Investments classified as Level 3 are valued using a discounted cash flow model. The assumptions used in preparing the discounted cash flow model include estimates for interest rates, amount of cash flows, expected holding periods of the securities and a discount to reflect the Company’s inability to liquidate the securities. The Company’s derivative instruments are valued using discounted cash flow models. The assumptions used in preparing the valuation models include foreign exchange rates, forward and spot prices for currencies and market observable data of similar instruments. Contractual maturities of investments The Company’s investments are reported at fair value, with unrealized gains and losses, net of tax, recorded as a component of accumulated other comprehensive income in the Consolidated Balance Sheet. The following summarizes the contractual underlying maturities of the Company’s available-for-sale investments and money market funds at April 3, 2021 (in thousands): Fair Cost Value Due in one year or less $ 270,863 $ 271,720 Due after one year through ten years 151,369 151,669 Due after ten years 18,800 18,062 $ 441,032 $ 441,451 Available-for-sale investments The available-for-sale investments that were in a continuous unrealized loss position, aggregated by length of time that individual securities have been in a continuous loss position, were as follows (in thousands): Less Than 12 Months 12 Months or Greater Total Gross Gross Gross Fair Unrealized Fair Unrealized Fair Unrealized As of April 3, 2021 Value Losses Value Losses Value Losses Government debt securities $ 6,719 $ (6) $ — $ — $ 6,719 $ (6) Corporate debt securities 59,542 (56) — — 59,542 (56) Auction rate securities — — 5,262 (738) 5,262 (738) $ 66,261 $ (62) $ 5,262 $ (738) $ 71,523 $ (800) Less Than 12 Months 12 Months or Greater Total Gross Gross Gross Fair Unrealized Fair Unrealized Fair Unrealized As of January 2, 2021 Value Losses Value Losses Value Losses Government debt securities $ 10,146 $ (5) $ — $ — $ 10,146 $ (5) Corporate debt securities 51,909 (74) — — 51,909 (74) Auction rate securities — — 5,340 (660) 5,340 (660) $ 62,055 $ (79) $ 5,340 $ (660) $ 67,395 $ (739) The gross unrealized losses as of April 3, 2021 and January 2, 2021 were due primarily to changes in market interest rates and the illiquidity of the Company’s auction-rate securities. The Company’s auction-rate securities have been illiquid since 2008 when auctions for the securities failed because sell orders exceeded buy orders. These securities have a contractual maturity date of 2046. The Company is unable to predict if these funds will become available before their maturity date. 3. Fair Value of Financial Instruments (Continued) The Company records an allowance for credit loss when a decline in investment market value is due to credit-related factors. When evaluating an investment for impairment, the Company reviews factors such as the severity of the impairment, changes in underlying credit ratings, forecasted recovery, the Company’s intent to sell or the likelihood that it would be required to sell the investment before its anticipated recovery in market value and the probability that the scheduled cash payments will continue to be made. As of April 3, 2021, there were no material declines in the market value of available-for-sale investments due to credit-related factors. At April 3, 2021 and January 2, 2021, there were no material unrealized gains associated with the Company’s available-for-sale investments. Level 3 fair value measurements The following summarizes quantitative information about Level 3 fair value measurements. Auction rate securities Fair Value at April 3, 2021 (000s) Valuation Technique Unobservable Input Weighted Average $ 5,262 Discounted cash flow Estimated yield 1.18 % Expected holding period 10 years Estimated discount rate 2.57 % Significant changes in any of the unobservable inputs used in the fair value measurement of auction rate securities in isolation could result in a significantly lower or higher fair value measurement. An increase in expected yield would result in a higher fair value measurement, whereas an increase in expected holding period or estimated discount rate would result in a lower fair value measurement. Generally, a change in the assumptions used for expected holding period is accompanied by a directionally similar change in the assumptions used for estimated yield and discount rate. The following summarizes the activity in Level 3 financial instruments for the three months ended April 3, 2021 (in thousands): Three Months Auction Rate Securities Ended Beginning balance $ 5,340 Loss included in other comprehensive loss (78) Balance at April 3, 2021 $ 5,262 Fair values of other financial instruments The Company’s debt is recorded at cost, but is measured at fair value for disclosure purposes. The fair value of the Company’s convertible senior notes is determined using observable market prices. The notes are traded in less active markets and are therefore classified as a Level 2 fair value measurement. As of April 3, 2021 and January 2, 2021, the fair value of the 0.625% convertible senior notes due in 2025 was $691.2 million and $671.4 million, respectively. The Company’s other financial instruments, including cash, accounts receivable and accounts payable, are recorded at amounts that approximate their fair values due to their short maturities. |
Derivative Financial Instrument
Derivative Financial Instruments | 3 Months Ended |
Apr. 03, 2021 | |
Derivative Financial Instruments | |
Derivative Financial Instruments | 4. Derivative Financial Instruments The Company uses derivative financial instruments to manage certain exposures to the variability of foreign currency exchange rates. The Company’s objective is to offset increases and decreases in expenses resulting from these exposures with gains and losses on the derivative contracts, thereby reducing volatility of earnings. The Company does not use derivative contracts for speculative or trading purposes. The Company recognizes derivatives, on a gross basis, in the Consolidated Balance Sheet at fair value. Cash flows from derivatives are classified according to the nature of the cash receipt or payment in the Consolidated Statement of Cash Flows. Cash Flow Hedges Foreign Currency Forward Contracts The Company uses foreign currency forward contracts to reduce the earnings impact that exchange rate fluctuations have on operating expenses denominated in currencies other than the U.S. dollar. Changes in the fair value of the contracts are recorded in accumulated other comprehensive income (loss) in the Consolidated Balance Sheet and subsequently reclassified into earnings in the period during which the hedged transaction is recognized. The reclassified amount is reported in the same financial statement line item as the hedged item. If the foreign currency forward contracts are terminated or can no longer qualify as hedging instruments prior to maturity, the fair value of the contracts recorded in accumulated other comprehensive income (loss) may be recognized in the Consolidated Statement of Income based on an assessment of the contracts at the time of termination. The Company has entered into foreign currency forward contracts for a portion of its forecasted operating expenses denominated in the Euro, Norwegian Krone and Hungarian Forint. As of April 3, 2021, the contracts had maturities of one Non-designated Hedges Foreign Currency Forward Contracts The Company uses foreign currency forward contracts to reduce the earnings impact that exchange rate fluctuations have on non-U.S. dollar balance sheet exposures. The Company recognizes gains and losses on the foreign currency forward contracts in interest income and other, net in the Consolidated Statement of Income in the same period as the remeasurement loss and gain of the related foreign currency denominated asset or liability. The Company does not apply hedge accounting to these foreign currency forward contracts. As of April 3, 2021, the Company held three foreign currency forward contracts denominated in Singapore Dollars with a notional value of $16.5 million. The fair value of foreign contracts and contract losses recognized in income were not material for any of the periods presented. |
Balance Sheet Details
Balance Sheet Details | 3 Months Ended |
Apr. 03, 2021 | |
Balance Sheet Details | |
Balance Sheet Details | 5. Balance Sheet Details The following shows the details of selected Condensed Consolidated Balance Sheet items (in thousands): Inventories April 3, January 2, 2021 2021 Work in progress $ 68,747 $ 56,165 Finished goods 10,497 10,497 $ 79,244 $ 66,662 |
Debt
Debt | 3 Months Ended |
Apr. 03, 2021 | |
Debt | |
Debt | 6. Debt 0.625% Convertible Senior Notes On June 1, 2020, the Company completed a private offering of $535 million principal amount convertible senior notes (the “2025 Notes”). The 2025 Notes bear interest semi-annually at a rate of 0.625% per year and mature on June 15, 2025. The 2025 Notes are convertible at an initial conversion rate of 8.1498 shares of common stock per $1,000 principal amount of the 2025 Notes, or approximately 4.4 million shares of common stock, which is equivalent to a conversion price of approximately $122.70 per share. The conversion rate is subject to adjustment under certain circumstances. Holders may convert the 2025 Notes under the following circumstances: during any calendar quarter after the calendar quarter ended on September 30, 2020 if the closing price of the Company’s common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is greater than or equal to $159.51 per share, representing 130% of the conversion price of the 2025 Notes; during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the closing sale price of our common stock and the conversion rate on each such trading day; if specified distributions or corporate events occur; if the Notes are called for redemption; or at any time after March 15, 2025. The Company may redeem all or any portion of the 2025 Notes, at its option, on or after June 20, 2023, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading day period. Upon conversion, the 2025 Notes may be settled in cash, shares of the Company’s common stock or a combination of cash and shares, at the Company’s election. The Company incurred debt issuance costs of approximately $10.4 million, which was allocated to the liability and equity components in proportion to the allocation of the proceeds. The costs allocated to the liability component are being amortized as interest expense over the term of the 2025 Notes using the effective interest method. 1.375% Convertible Senior Notes On March 6, 2017, the Company completed a private offering of $400 million principal amount convertible senior notes (the “2022 Notes”). The Notes bore interest semi-annually at a rate of 1.375% per year and were scheduled to mature on March 1, 2022. On January 6, 2021, the Company issued a notice of redemption for the remaining $140.6 million principal amount of the 2022 Notes. Prior to the redemption, the Company received conversion notices representing $130.4 million principal amount of the notes. The Company paid $130.4 million in cash and issued 528,022 shares of common stock for the conversions. Notes representing $10.2 million principal amount were redeemed at par, plus accrued interest. All note conversions and redemptions were completed by March 22, 2021. The Company recognized a loss on debt extinguishment of $3.4 million during the three months ended April 3, 2021, which was recorded in interest expense in the Condensed Consolidated Statements of Income. Convertible Debt, Net The principal balances of the 2025 Notes and 2022 Notes (together, the “Notes”) were separated into liability and equity components, and recorded initially at fair value. The excess of the principal amounts of the liability components over their carrying amounts represent the debt discount, which are amortized to interest expense over the term of the Notes using the effective interest method. The carrying amounts of the liability components was estimated by discounting the contractual cash flows of similar non-convertible debt at an appropriate market rate at the date of issuance. 6. Debt (Continued) The carrying amount of the Notes consisted of the following (in thousands): April 3, January 2, 2021 2021 Liability component Principal $ 535,000 $ 675,567 Unamortized debt discount (93,693) (103,953) Unamortized debt issuance costs (7,019) (8,189) Net carrying amount $ 434,288 $ 563,425 Equity component Net carrying amount $ 107,927 $ 108,438 The liability components of the Notes are recorded in convertible debt on the Consolidated Balance Sheet. The equity components of the Notes are recorded in additional paid-in capital. The effective interest rate for the liability component was 5.336% for the 2025 Notes and 4.75 % for the 2022 Notes. As of April 3, 2021, the remaining period over which the debt discount and debt issuance costs will be amortized was 4.2 years for the 2025 Notes. Interest expense related to the Notes was comprised of the following (in thousands): Three Months Ended April 3, April 4, 2021 2020 Contractual interest expense $ 1,163 $ 1,467 Amortization of debt discount 5,938 3,246 Amortization of debt issuance costs 518 490 $ 7,619 $ 5,203 Credit Facility The Company and certain of its domestic subsidiaries (the “Guarantors”) have a $400 million revolving credit facility with a maturity date of August 7, 2024. The credit facility includes a $25 million letter of credit sublimit and a $10 million swingline loan sublimit. The Company also has an option to increase the size of the borrowing capacity by up to the greater of an aggregate of $250 million and 100% of EBITDA, plus an amount that would not cause a secured leverage ratio (funded debt secured by assets/EBITDA) to exceed 3.25 to 1.00, subject to certain conditions. The credit facility, other than swingline loans, will bear interest at the Eurodollar rate plus an applicable margin or, at the option of the Company, a base rate (defined as the highest of the Wells Fargo prime rate, the Federal Funds rate plus 0.50% and the Eurodollar Base Rate plus 1.00%) plus an applicable margin. Swingline loans accrue interest at the base rate plus the applicable margin for base rate loans. The applicable margins for the Eurodollar rate loans range from 1.00% to 1.75% and for base rate loans range from 0.00% to 0.75%, depending in each case, on the leverage ratio as defined in the credit facility. The credit facility contains various conditions, covenants and representations with which the Company must be in compliance in order to borrow funds and to avoid an event of default, including financial covenants that the Company must maintain a net leverage ratio (funded indebtedness/EBITDA) of no more than 4.25 to 1, a secured leverage ratio of no more than 3.50 to 1, and a minimum interest coverage ratio (EBITDA/interest payments) of no less than 2.50 to 1. As of April 3, 2021, the Company was in compliance with all covenants of the credit facility. The Company’s obligations under the credit facility are guaranteed by the Guarantors and are secured by a security interest in substantially all assets of the Company and the Guarantors. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Apr. 03, 2021 | |
Commitments and Contingencies | |
Commitments and Contingencies | 7. Commitments and Contingencies Legal Proceedings The Company is involved in various legal proceedings that have arisen in the normal course of business. While the ultimate results cannot be predicted with certainty, the Company does not expect them to have a material adverse effect on its Consolidated Financial Statements. |
Revenues
Revenues | 3 Months Ended |
Apr. 03, 2021 | |
Revenues | |
Revenues | 8. Revenues The Company groups its revenues into two categories, based on the markets and applications in which its products may be used. The following disaggregates the Company's revenue by product category (in thousands): Three Months Ended April 3, April 4, 2021 2020 Internet of Things $ 158,245 $ 118,041 Infrastructure and automotive 97,260 96,836 $ 255,505 $ 214,877 A portion of the Company's sales are made to distributors under agreements allowing certain rights of return and/or price protection related to the final selling price to the end customers. These factors impact the timing and uncertainty of revenues and cash flows. During the three months ended April 3, 2021 and April 4, 2020, the Company recognized revenue of $12.0 million and $11.1 million, respectively, from performance obligations that were satisfied in previous reporting periods. The following disaggregates the Company's revenue by sales channel (in thousands): Three Months Ended April 3, April 4, 2021 2020 Distributors $ 202,266 $ 163,463 Direct customers 53,239 51,414 $ 255,505 $ 214,877 |
Stock-Based Compensation
Stock-Based Compensation | 3 Months Ended |
Apr. 03, 2021 | |
Stock-Based Compensation | |
Stock-Based Compensation | 9. Stock-Based Compensation In fiscal 2009, the stockholders of the Company approved the 2009 Stock Incentive Plan (the “2009 Plan”) and the 2009 Employee Stock Purchase Plan (the “2009 Purchase Plan”). In fiscal 2017, the stockholders of the Company approved amendments to both the 2009 Plan and the 2009 Purchase Plan. The purpose of the amendments was to authorize additional shares of common stock for issuance, to comply with changes in applicable law, to improve the Company’s corporate governance and to implement other best practices. Stock-based compensation costs are based on the fair values on the date of grant for stock awards and stock options and on the date of enrollment for the employee stock purchase plans. The fair values of stock awards (such as restricted stock awards (RSUs), performance stock units (PSUs) and restricted stock awards (RSAs)) are estimated based on their intrinsic values. The fair values of market stock awards (MSUs) are estimated using a Monte Carlo simulation. The fair values of stock options and employee stock purchase plans are estimated using the Black-Scholes option-pricing model. 9. Stock-Based Compensation (Continued) The following table presents details of stock-based compensation costs recognized in the Condensed Consolidated Statements of Income (in thousands): Three Months Ended April 3, April 4, 2021 2020 Cost of revenues $ 337 $ 335 Research and development 7,024 7,370 Selling, general and administrative 6,465 7,608 13,826 15,313 Income tax benefit 1,665 1,366 $ 12,161 $ 13,947 The Company had approximately $66.0 million of total unrecognized compensation costs related to equity grants from the 2009 Plan as of April 3, 2021 that are expected to be recognized over a weighted-average period of approximately 2.0 years. There were no significant stock-based compensation costs capitalized into assets in any of the periods presented. |
Income Taxes
Income Taxes | 3 Months Ended |
Apr. 03, 2021 | |
Income Taxes | |
Income Taxes | 10. Income Taxes Provision (benefit) for income taxes includes both domestic and foreign income taxes at the applicable tax rates adjusted for non-deductible expenses, research and development tax credits and other permanent differences. Income tax expense (benefit) was The higher provision for income taxes for the three months ended April 3, 2021 was primarily due to higher profits, partially offset by the amount of income earned in foreign jurisdictions where the tax rate may be lower than the federal statutory rate, as well as permanent items including excess tax benefits from stock-based awards and the federal research and development credit. The benefit from income taxes for the three months ended April 4, 2020 was primarily due to lower profits relative to the amount of income earned in foreign jurisdictions where the tax rate may be lower than the federal statutory rate, as well as the increased impact of permanent items including the federal research and development credit, the tax effects of non-deductible stock-based compensation, global intangible low-tax income (“GILTI”) and excess tax benefits from stock-based awards. Uncertain Tax Positions As of April 3, 2021, the Company had gross unrecognized tax benefits, inclusive of interest, of $3.2 million, of which $2.5 million would affect the effective tax rate if recognized. During the three months ended April 3, 2021, the Company did not release any of its unrecognized tax benefits. The Company recognizes interest and penalties related to unrecognized tax benefits in the provision (benefit) for income taxes. These amounts were not material for any of the periods presented. Following the completion of the Norwegian Tax Administration (“NTA”) examination of the Company’s Norwegian subsidiary for income tax matters relating to fiscal years 2013 - 2016, the Company received an assessment from the NTA in December 2017 concerning an adjustment to its 2013 taxable income related to the pricing of an intercompany transaction. The Company is currently appealing the assessment. The adjustment to the pricing of the intercompany transaction results in approximately 141.3 million Norwegian kroner, or $16.6 million additional Norwegian income tax. The Company disagrees with the NTA’s assessment and believes the Company’s position on this matter is more likely than not to be sustained. The Company plans to exhaust all available administrative remedies, and if unable to resolve this matter through administrative remedies with the NTA, the Company plans to pursue judicial remedies. 10. Income Taxes (Continued) The Company believes that it has accrued adequate reserves related to all matters contained in tax periods open to examination. Should the Company experience an unfavorable outcome in the NTA matter, however, such an outcome could have a material impact on its financial statements. Tax years 2015 through 2021 remain open to examination by the major taxing jurisdictions in which the Company operates. The Company is not currently under audit in any major taxing jurisdiction. The Company does not expect material changes to its gross unrecognized tax benefits in the next 12 months. |
Subsequent Event
Subsequent Event | 3 Months Ended |
Apr. 03, 2021 | |
Subsequent Event | |
Subsequent Event | 11. Subsequent Event On April 22, 2021, the Company entered into an Asset Purchase Agreement pursuant to which Skyworks Solutions, Inc. has agreed to acquire certain assets, rights, and properties, and assume certain liabilities, comprising the Company’s infrastructure and automotive business for $2.75 billion in cash. The Company cannot estimate the amount of the gain to be recorded upon the close of the sale at this time. The Company has determined that the criteria for classification as held for sale for the infrastructure and automotive business were met beginning in the second quarter of fiscal 2021. As a result, the assets and liabilities of the infrastructure and automotive business will be classified as held for sale and financial results of the business will be reported as income from discontinued operations beginning in the second quarter of fiscal 2021. The transaction is subject to regulatory approval and other customary closing conditions and is expected to be closed in the third quarter of fiscal 2021. |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 3 Months Ended |
Apr. 03, 2021 | |
Significant Accounting Policies | |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Among the significant estimates affecting the financial statements are those related to inventories, goodwill, acquired intangible assets, other long-lived assets, revenue recognition, stock-based compensation and income taxes. Actual results could differ from those estimates, and such differences could be material to the financial statements. |
Revenue Recognition | Revenue Recognition Revenue is recognized when control of the promised goods or services is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Substantially all of the Company’s contracts with customers contain a single performance obligation, the sale of mixed-signal integrated circuit (IC) products. This performance obligation is satisfied when control of the product is transferred to the customer, which typically occurs upon delivery. Unsatisfied performance obligations primarily represent contracts for products with future delivery dates. The Company has opted to not disclose the amount of unsatisfied performance obligations as these contracts have original expected durations of less than one year. The transaction price reflects the Company’s expectations about the consideration it will be entitled to receive from the customer and may include fixed or variable amounts. Variable consideration primarily includes sales made to distributors under agreements allowing certain rights of return, referred to as stock rotation, and credits issued to the distributor due to price protection. The Company estimates variable consideration at the most likely amount to which it expects to be entitled. The estimate is based on information available to the Company, including recent sales activity and pricing data. The Company applies a constraint to its variable consideration estimate which considers both the likelihood of a return and the amount of a potential price concession. Variable consideration that does not meet revenue recognition criteria is deferred. The Company records a right of return asset in prepaid expenses and other current assets for the costs of distributor inventory not meeting revenue recognition criteria. A corresponding deferred revenue and returns liability amount is recorded for unrecognized revenue associated with such costs. The Company’s products carry a one-year replacement warranty. Payments are typically due within 30 days of invoicing and do not include a significant financing component. 1. Significant Accounting Policies (Continued) |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40) |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 3 Months Ended |
Apr. 03, 2021 | |
Earnings Per Share | |
Schedule of computation of basic and diluted earnings per share | The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data): Three Months Ended April 3, April 4, 2021 2020 Net income $ 13,509 $ 2,244 Shares used in computing basic earnings per share 44,160 43,642 Effect of dilutive securities: Stock-based awards and convertible debt 1,672 746 Shares used in computing diluted earnings per share 45,832 44,388 Earnings per share: Basic $ 0.31 $ 0.05 Diluted $ 0.29 $ 0.05 |
Fair Value of Financial Instr_2
Fair Value of Financial Instruments (Tables) | 3 Months Ended |
Apr. 03, 2021 | |
Fair Value of Financial Instruments | |
Summary of valuation of the financial instruments | The following summarizes the valuation of the Company’s financial instruments (in thousands). The tables do not include either cash on hand or assets and liabilities that are measured at historical cost or any basis other than fair value. Fair Value Measurements at April 3, 2021 Using Quoted Prices in Significant Other Significant Active Markets for Observable Unobservable Identical Assets Inputs Inputs Description (Level 1) (Level 2) (Level 3) Total Assets: Cash equivalents: Money market funds $ 67,279 $ — $ — $ 67,279 Corporate debt securities — 1,202 — 1,202 Total cash equivalents $ 67,279 $ 1,202 $ — $ 68,481 Short-term investments: Government debt securities $ 5,226 $ 80,124 $ — $ 85,350 Corporate debt securities — 282,358 — 282,358 Total short-term investments $ 5,226 $ 362,482 $ — $ 367,708 Other assets, net: Auction rate securities $ — $ — $ 5,262 $ 5,262 Total $ — $ — $ 5,262 $ 5,262 Total $ 72,505 $ 363,684 $ 5,262 $ 441,451 Fair Value Measurements at January 2, 2021 Using Quoted Prices in Significant Other Significant Active Markets for Observable Unobservable Identical Assets Inputs Inputs Description (Level 1) (Level 2) (Level 3) Total Assets: Cash equivalents: Money market funds $ 75,606 $ — $ — $ 75,606 Corporate debt securities — 14,995 — 14,995 Government debt securities 2,355 2,564 — 4,919 Total cash equivalents $ 77,961 $ 17,559 $ — $ 95,520 Short-term investments: Government debt securities $ 38,461 $ 104,112 $ — $ 142,573 Corporate debt securities — 379,390 — 379,390 Total short-term investments $ 38,461 $ 483,502 $ — $ 521,963 Other assets, net: Auction rate securities $ — $ — $ 5,340 $ 5,340 Total $ — $ — $ 5,340 $ 5,340 Total $ 116,422 $ 501,061 $ 5,340 $ 622,823 |
Schedule of maturities of the Company's available-for-sale investments and money market funds | The following summarizes the contractual underlying maturities of the Company’s available-for-sale investments and money market funds at April 3, 2021 (in thousands): Fair Cost Value Due in one year or less $ 270,863 $ 271,720 Due after one year through ten years 151,369 151,669 Due after ten years 18,800 18,062 $ 441,032 $ 441,451 |
Schedule of available-for-sale investments in continuous unrealized loss position by length of time | The available-for-sale investments that were in a continuous unrealized loss position, aggregated by length of time that individual securities have been in a continuous loss position, were as follows (in thousands): Less Than 12 Months 12 Months or Greater Total Gross Gross Gross Fair Unrealized Fair Unrealized Fair Unrealized As of April 3, 2021 Value Losses Value Losses Value Losses Government debt securities $ 6,719 $ (6) $ — $ — $ 6,719 $ (6) Corporate debt securities 59,542 (56) — — 59,542 (56) Auction rate securities — — 5,262 (738) 5,262 (738) $ 66,261 $ (62) $ 5,262 $ (738) $ 71,523 $ (800) Less Than 12 Months 12 Months or Greater Total Gross Gross Gross Fair Unrealized Fair Unrealized Fair Unrealized As of January 2, 2021 Value Losses Value Losses Value Losses Government debt securities $ 10,146 $ (5) $ — $ — $ 10,146 $ (5) Corporate debt securities 51,909 (74) — — 51,909 (74) Auction rate securities — — 5,340 (660) 5,340 (660) $ 62,055 $ (79) $ 5,340 $ (660) $ 67,395 $ (739) |
Summary of quantitative information about level 3 fair value measurements | Auction rate securities Fair Value at April 3, 2021 (000s) Valuation Technique Unobservable Input Weighted Average $ 5,262 Discounted cash flow Estimated yield 1.18 % Expected holding period 10 years Estimated discount rate 2.57 % |
Summary of activity in Level 3 financial instruments | The following summarizes the activity in Level 3 financial instruments for the three months ended April 3, 2021 (in thousands): Three Months Auction Rate Securities Ended Beginning balance $ 5,340 Loss included in other comprehensive loss (78) Balance at April 3, 2021 $ 5,262 |
Balance Sheet Details (Tables)
Balance Sheet Details (Tables) | 3 Months Ended |
Apr. 03, 2021 | |
Balance Sheet Details | |
Schedule of Inventories | The following shows the details of selected Condensed Consolidated Balance Sheet items (in thousands): Inventories April 3, January 2, 2021 2021 Work in progress $ 68,747 $ 56,165 Finished goods 10,497 10,497 $ 79,244 $ 66,662 |
Debt (Tables)
Debt (Tables) | 3 Months Ended |
Apr. 03, 2021 | |
Debt | |
Summary of information about the equity and liability components of convertible debt | 6. Debt (Continued) The carrying amount of the Notes consisted of the following (in thousands): April 3, January 2, 2021 2021 Liability component Principal $ 535,000 $ 675,567 Unamortized debt discount (93,693) (103,953) Unamortized debt issuance costs (7,019) (8,189) Net carrying amount $ 434,288 $ 563,425 Equity component Net carrying amount $ 107,927 $ 108,438 |
Schedule of components of interest expense | Interest expense related to the Notes was comprised of the following (in thousands): Three Months Ended April 3, April 4, 2021 2020 Contractual interest expense $ 1,163 $ 1,467 Amortization of debt discount 5,938 3,246 Amortization of debt issuance costs 518 490 $ 7,619 $ 5,203 |
Revenues (Tables)
Revenues (Tables) | 3 Months Ended |
Apr. 03, 2021 | |
Revenues | |
Schedule of disaggregation of revenue by product category | The following disaggregates the Company's revenue by product category (in thousands): Three Months Ended April 3, April 4, 2021 2020 Internet of Things $ 158,245 $ 118,041 Infrastructure and automotive 97,260 96,836 $ 255,505 $ 214,877 |
Schedule of disaggregation of revenue by sales channel | The following disaggregates the Company's revenue by sales channel (in thousands): Three Months Ended April 3, April 4, 2021 2020 Distributors $ 202,266 $ 163,463 Direct customers 53,239 51,414 $ 255,505 $ 214,877 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 3 Months Ended |
Apr. 03, 2021 | |
Stock-Based Compensation | |
Schedule of stock-based compensation costs recognized in the Condensed Consolidated Statements of Income | 9. Stock-Based Compensation (Continued) The following table presents details of stock-based compensation costs recognized in the Condensed Consolidated Statements of Income (in thousands): Three Months Ended April 3, April 4, 2021 2020 Cost of revenues $ 337 $ 335 Research and development 7,024 7,370 Selling, general and administrative 6,465 7,608 13,826 15,313 Income tax benefit 1,665 1,366 $ 12,161 $ 13,947 |
Significant Accounting Polici_3
Significant Accounting Policies (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | |
Apr. 03, 2021 | Jan. 02, 2021 | Jan. 02, 2022 | |
Significant Accounting Policies | |||
Length of fiscal year | 364 days | 371 days | |
Number of days in each fiscal quarter for 52-week fiscal year | 91 days | ||
Minimum | |||
Significant Accounting Policies | |||
Length of fiscal year | 364 days | ||
Maximum | |||
Significant Accounting Policies | |||
Length of fiscal year | 371 days | ||
Cumulative effect of adoption of accounting standard | Accounting Standards Update 2020-06 | Forecast | |||
Significant Accounting Policies | |||
Increase in carrying value of convertible debt | $ 78.5 |
Earnings Per Share (Details)
Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | |
Apr. 03, 2021 | Apr. 04, 2020 | |
Earnings Per Share | ||
Net income | $ 13,509 | $ 2,244 |
Shares used in computing basic earnings per share | 44,160 | 43,642 |
Effect of dilutive securities: | ||
Stock-based awards and convertible debt | 1,672 | 746 |
Shares used in computing diluted earnings per share | 45,832 | 44,388 |
Earnings per share: | ||
Basic (in dollars per share) | $ 0.31 | $ 0.05 |
Diluted (in dollars per share) | $ 0.29 | $ 0.05 |
Shares attributable to dilutive effect of conversion of debt securities | 1,100 | 300 |
Fair Value of Financial Instr_3
Fair Value of Financial Instruments - Summary of financial instruments (Details) - USD ($) $ in Thousands | Apr. 03, 2021 | Jan. 02, 2021 |
Financial assets and liabilities measured at fair value on a recurring basis | ||
Short-term investments | $ 367,708 | $ 521,963 |
Recurring | ||
Financial assets and liabilities measured at fair value on a recurring basis | ||
Cash equivalents | 68,481 | 95,520 |
Short-term investments | 367,708 | 521,963 |
Other assets, net | 5,262 | 5,340 |
Total assets at fair value | 441,451 | 622,823 |
Recurring | Money market funds | ||
Financial assets and liabilities measured at fair value on a recurring basis | ||
Cash equivalents | 67,279 | 75,606 |
Recurring | Corporate debt securities | ||
Financial assets and liabilities measured at fair value on a recurring basis | ||
Cash equivalents | 1,202 | 14,995 |
Short-term investments | 282,358 | 379,390 |
Recurring | Government debt securities | ||
Financial assets and liabilities measured at fair value on a recurring basis | ||
Cash equivalents | 4,919 | |
Short-term investments | 85,350 | 142,573 |
Recurring | Auction rate securities | ||
Financial assets and liabilities measured at fair value on a recurring basis | ||
Other assets, net | 5,262 | 5,340 |
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Financial assets and liabilities measured at fair value on a recurring basis | ||
Cash equivalents | 67,279 | 77,961 |
Short-term investments | 5,226 | 38,461 |
Total assets at fair value | 72,505 | 116,422 |
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Money market funds | ||
Financial assets and liabilities measured at fair value on a recurring basis | ||
Cash equivalents | 67,279 | 75,606 |
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Government debt securities | ||
Financial assets and liabilities measured at fair value on a recurring basis | ||
Cash equivalents | 2,355 | |
Short-term investments | 5,226 | 38,461 |
Recurring | Significant Other Observable Inputs (Level 2) | ||
Financial assets and liabilities measured at fair value on a recurring basis | ||
Cash equivalents | 1,202 | 17,559 |
Short-term investments | 362,482 | 483,502 |
Total assets at fair value | 363,684 | 501,061 |
Recurring | Significant Other Observable Inputs (Level 2) | Corporate debt securities | ||
Financial assets and liabilities measured at fair value on a recurring basis | ||
Cash equivalents | 1,202 | 14,995 |
Short-term investments | 282,358 | 379,390 |
Recurring | Significant Other Observable Inputs (Level 2) | Government debt securities | ||
Financial assets and liabilities measured at fair value on a recurring basis | ||
Cash equivalents | 2,564 | |
Short-term investments | 80,124 | 104,112 |
Recurring | Significant Unobservable Inputs (Level 3) | ||
Financial assets and liabilities measured at fair value on a recurring basis | ||
Other assets, net | 5,262 | 5,340 |
Total assets at fair value | 5,262 | 5,340 |
Recurring | Significant Unobservable Inputs (Level 3) | Auction rate securities | ||
Financial assets and liabilities measured at fair value on a recurring basis | ||
Other assets, net | $ 5,262 | $ 5,340 |
Fair Value of Financial Instr_4
Fair Value of Financial Instruments - Contractual maturities of investments (Details) - USD ($) $ in Thousands | Apr. 03, 2021 | Jan. 02, 2021 |
Cost | ||
Due in one year or less, Cost | $ 270,863 | |
Due after one year through ten years, Cost | 151,369 | |
Due after ten years, Cost | 18,800 | |
Total Cost | 441,032 | |
Fair Value | ||
Due in one year or less, Fair Value | 271,720 | |
Due after one year through ten years, Fair Value | 151,669 | |
Due after ten years, Fair Value | 18,062 | |
Total Fair Value | 441,451 | |
Continuous unrealized loss position, Fair Value | ||
Fair value of available-for-sale securities, continuous loss position for less than twelve months | 66,261 | $ 62,055 |
Fair value of available-for-sale securities, continuous loss position for twelve months or greater | 5,262 | 5,340 |
Total fair value of available-for-sale securities, continuous loss position | 71,523 | 67,395 |
Continuous unrealized loss position, Gross Unrealized Losses | ||
Available-for-sale securities, continuous loss position for less than 12 months, gross unrealized losses | (62) | (79) |
Available-for-sale securities, continuous loss position for 12 months or greater, gross unrealized losses | (738) | (660) |
Available-for-sale securities, total gross unrealized losses | (800) | (739) |
Government debt securities | ||
Continuous unrealized loss position, Fair Value | ||
Fair value of available-for-sale securities, continuous loss position for less than twelve months | 6,719 | 10,146 |
Total fair value of available-for-sale securities, continuous loss position | 6,719 | 10,146 |
Continuous unrealized loss position, Gross Unrealized Losses | ||
Available-for-sale securities, continuous loss position for less than 12 months, gross unrealized losses | (6) | (5) |
Available-for-sale securities, total gross unrealized losses | (6) | (5) |
Corporate debt securities | ||
Continuous unrealized loss position, Fair Value | ||
Fair value of available-for-sale securities, continuous loss position for less than twelve months | 59,542 | 51,909 |
Total fair value of available-for-sale securities, continuous loss position | 59,542 | 51,909 |
Continuous unrealized loss position, Gross Unrealized Losses | ||
Available-for-sale securities, continuous loss position for less than 12 months, gross unrealized losses | (56) | (74) |
Available-for-sale securities, total gross unrealized losses | (56) | (74) |
Auction rate securities | ||
Continuous unrealized loss position, Fair Value | ||
Fair value of available-for-sale securities, continuous loss position for twelve months or greater | 5,262 | 5,340 |
Total fair value of available-for-sale securities, continuous loss position | 5,262 | 5,340 |
Continuous unrealized loss position, Gross Unrealized Losses | ||
Available-for-sale securities, continuous loss position for 12 months or greater, gross unrealized losses | (738) | (660) |
Available-for-sale securities, total gross unrealized losses | $ (738) | $ (660) |
Fair Value of Financial Instr_5
Fair Value of Financial Instruments - Auction rate securities (Details) - Auction rate securities - Significant Unobservable Inputs (Level 3) $ in Thousands | Apr. 03, 2021USD ($)itemY | Jan. 02, 2021USD ($) |
Weighted Average | Estimated yield | Discounted cash flow | ||
Quantitative information for Level 3 Fair Value Measurements Assets | ||
Unobservable Input | 0.0118 | |
Weighted Average | Expected holding period | Discounted cash flow | ||
Quantitative information for Level 3 Fair Value Measurements Assets | ||
Unobservable Input | Y | 10 | |
Weighted Average | Estimated discount rate | Discounted cash flow | ||
Quantitative information for Level 3 Fair Value Measurements Assets | ||
Unobservable Input | 0.0257 | |
Recurring | ||
Quantitative information for Level 3 Fair Value Measurements Assets | ||
Fair value balance at the end of the period | $ | $ 5,262 | $ 5,340 |
Fair Value of Financial Instr_6
Fair Value of Financial Instruments - Activity in Level 3 financial instruments (Details) - Significant Unobservable Inputs (Level 3) - Recurring - Auction rate securities $ in Thousands | 3 Months Ended |
Apr. 03, 2021USD ($) | |
Fair value assets reconciliation of changes | |
Balance at the beginning of the period | $ 5,340 |
Loss included in other comprehensive loss | (78) |
Balance at the end of the period | $ 5,262 |
Fair Value of Financial Instr_7
Fair Value of Financial Instruments - Fair values of other financial instruments (Details) - USD ($) $ in Millions | Apr. 03, 2021 | Jan. 02, 2021 | Jun. 01, 2020 | Mar. 06, 2017 |
0.625% Convertible Senior Notes (2025 Notes) | ||||
Fair values of other financial instruments | ||||
Interest rate (as a percent) | 0.625% | 0.625% | ||
Fair value of debt | $ 691.2 | $ 671.4 | ||
1.375% Convertible Senior Notes (2022 Notes) | ||||
Fair values of other financial instruments | ||||
Interest rate (as a percent) | 1.375% |
Derivative Financial Instrume_2
Derivative Financial Instruments (Details) - Foreign currency forward contracts $ in Millions | 3 Months Ended |
Apr. 03, 2021USD ($)contract | |
Non-designated Hedges | |
Derivative Financial Instruments | |
Number of foreign currency forward contracts held | contract | 3 |
Non-designated Hedges | Singapore Dollars | |
Derivative Financial Instruments | |
Derivative, notional amount | $ 16.5 |
Cash flow hedges | |
Derivative Financial Instruments | |
Derivative, notional amount | $ 22 |
Cash flow hedges | Minimum | |
Derivative Financial Instruments | |
Maturity of contracts | 1 month |
Cash flow hedges | Maximum | |
Derivative Financial Instruments | |
Maturity of contracts | 12 months |
Balance Sheet Details (Details)
Balance Sheet Details (Details) - USD ($) $ in Thousands | Apr. 03, 2021 | Jan. 02, 2021 |
Inventories | ||
Work in progress | $ 68,747 | $ 56,165 |
Finished goods | 10,497 | 10,497 |
Inventories | $ 79,244 | $ 66,662 |
Debt - Convertible Senior Notes
Debt - Convertible Senior Notes (Details) $ / shares in Units, $ in Thousands | Jan. 06, 2021USD ($)shares | Jun. 01, 2020USD ($)D$ / shares | Apr. 03, 2021USD ($) | Mar. 06, 2017USD ($) |
Debt | ||||
Loss on debt extinguishment | $ (3,370) | |||
Payments for repurchase of notes | $ 140,572 | |||
0.625% Convertible Senior Notes (2025 Notes) | ||||
Debt | ||||
Principal amount | $ 535,000 | |||
Semi-annual interest rate | 0.625% | 0.625% | ||
Conversion rate, shares per $1,000 principal | 8.1498 | |||
Conversion, number of shares of common stock | 4,400 | |||
Initial conversion price | $ / shares | $ 122.70 | |||
Debt issuance costs | $ 10,400 | |||
0.625% Convertible Senior Notes (2025 Notes) | Conversion of Notes, Holders | ||||
Debt | ||||
Number of trading days within 30 trading day period | D | 20 | |||
Number of consecutive trading days | D | 30 | |||
Stock price trigger per share | $ / shares | $ 159.51 | |||
Stock price trigger, as a percentage of conversion price | 130.00% | |||
Number of consecutive business days after the 10 consecutive trading day period | D | 5 | |||
Number of consecutive trading days before the five consecutive business days | D | 10 | |||
Maximum threshold stock price, as a percentage of conversion price | 98.00% | |||
0.625% Convertible Senior Notes (2025 Notes) | Conversion of Notes, Company | ||||
Debt | ||||
Number of trading days within 30 trading day period | D | 20 | |||
Number of consecutive trading days | D | 30 | |||
Stock price trigger, as a percentage of conversion price | 130.00% | |||
1.375% Convertible Senior Notes (2022 Notes) | ||||
Debt | ||||
Principal amount | $ 400,000 | |||
Semi-annual interest rate | 1.375% | |||
1.375% Convertible Senior Notes (2022 Notes) | Conversion of Notes, Holders | ||||
Debt | ||||
Principal amount of notes for conversion | $ 130,400 | |||
Cash paid upon conversion | $ 130,400 | |||
Number of shares issued in connection with conversion | shares | 528,022 | |||
Debt amount redeemed | $ 10,200 | |||
1.375% Convertible Senior Notes (2022 Notes) | Conversion of Notes, Holders | Interest expense | ||||
Debt | ||||
Loss on debt extinguishment | $ 3,400 | |||
1.375% Convertible Senior Notes (2022 Notes) | Conversion of Notes, Company | ||||
Debt | ||||
Remaining principal amount | $ 140,600 |
Debt - Carrying amount of Notes
Debt - Carrying amount of Notes (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Apr. 03, 2021 | Jan. 02, 2021 | |
0.625% Convertible Senior Notes (2025 Notes) | ||
Equity component | ||
Effective interest rate | 5.336% | |
Amortization period of debt discount and debt issuance costs | 4 years 2 months 12 days | |
1.375% Convertible Senior Notes (2022 Notes) | ||
Equity component | ||
Effective interest rate | 4.75% | |
Convertible Senior Notes | ||
Liability component | ||
Principal | $ 535,000 | $ 675,567 |
Unamortized debt discount | (93,693) | (103,953) |
Unamortized debt issuance costs | (7,019) | (8,189) |
Net carrying amount | 434,288 | 563,425 |
Equity component | ||
Net carrying amount | $ 107,927 | $ 108,438 |
Debt - Interest expense (Detail
Debt - Interest expense (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Apr. 03, 2021 | Apr. 04, 2020 | |
Interest expense related to the notes | ||
Interest Expense, Total | $ 11,324 | $ 5,541 |
Convertible Senior Notes | ||
Interest expense related to the notes | ||
Contractual interest expense | 1,163 | 1,467 |
Amortization of debt discount | 5,938 | 3,246 |
Amortization of debt issuance costs | 518 | 490 |
Interest Expense, Total | $ 7,619 | $ 5,203 |
Debt - Credit Facility (Details
Debt - Credit Facility (Details) $ in Millions | 3 Months Ended |
Apr. 03, 2021USD ($) | |
Credit Facility | Scenario: Company's option to increase borrowing capacity | |
Debt | |
Additional increase in borrowing capacity of the line of credit available at the entity's option | $ 250 |
Additional increase in borrowing capacity based on EBITDA (as a percent) | 100.00% |
Maximum secured leverage ratio | 3.25 |
Credit Facility | Scenario: Credit facility debt covenants | |
Debt | |
Maximum net leverage ratio | 4.25 |
Maximum secured leverage ratio | 3.50 |
Minimum interest coverage ratio | 2.50 |
Revolving Credit Facility | |
Debt | |
Maximum borrowing capacity | $ 400 |
Revolving credit facility, other than swingline loans | Federal Funds | |
Debt | |
Interest rate margin (as a percent) | 0.50% |
Revolving credit facility, other than swingline loans | Eurodollar Rate | |
Debt | |
Interest rate margin (as a percent) | 1.00% |
Revolving credit facility, other than swingline loans | Eurodollar Rate | Minimum | |
Debt | |
Interest rate margin (as a percent) | 1.00% |
Revolving credit facility, other than swingline loans | Eurodollar Rate | Maximum | |
Debt | |
Interest rate margin (as a percent) | 1.75% |
Revolving credit facility, other than swingline loans | Base Rate | Minimum | |
Debt | |
Interest rate margin (as a percent) | 0.00% |
Revolving credit facility, other than swingline loans | Base Rate | Maximum | |
Debt | |
Interest rate margin (as a percent) | 0.75% |
Letter of Credit | |
Debt | |
Maximum borrowing capacity | $ 25 |
Swingline Loans | |
Debt | |
Maximum borrowing capacity | $ 10 |
Revenues (Details)
Revenues (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Apr. 03, 2021 | Apr. 04, 2020 | |
Revenues | ||
Revenues | $ 255,505 | $ 214,877 |
Revenue from performance obligations that were satisfied in previous reporting periods | 12,000 | 11,100 |
Distributors | ||
Revenues | ||
Revenues | 202,266 | 163,463 |
Direct customers | ||
Revenues | ||
Revenues | 53,239 | 51,414 |
Internet of Things | ||
Revenues | ||
Revenues | 158,245 | 118,041 |
Infrastructure and automotive | ||
Revenues | ||
Revenues | $ 97,260 | $ 96,836 |
Stock-Based Compensation (Detai
Stock-Based Compensation (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Apr. 03, 2021 | Apr. 04, 2020 | |
Stock-based compensation costs | ||
Stock based compensation costs | $ 13,826 | $ 15,313 |
Income tax benefit | 1,665 | 1,366 |
Share based compensation costs after tax | 12,161 | 13,947 |
Total unrecognized compensation costs related to awards | $ 66,000 | |
Weighted-average period of recognition of unrecognized compensation costs | 2 years | |
Cost of revenues | ||
Stock-based compensation costs | ||
Stock based compensation costs | $ 337 | 335 |
Research and development | ||
Stock-based compensation costs | ||
Stock based compensation costs | 7,024 | 7,370 |
Selling, general and administrative | ||
Stock-based compensation costs | ||
Stock based compensation costs | $ 6,465 | $ 7,608 |
Income Taxes (Details)
Income Taxes (Details) $ in Thousands, kr in Millions | 3 Months Ended | ||
Apr. 03, 2021USD ($) | Apr. 03, 2021NOK (kr) | Apr. 04, 2020USD ($) | |
Income Taxes | |||
Provision (benefit) for income taxes | $ 201 | $ (587) | |
Effective income tax rate (as a percent) | 1.50% | 1.50% | (35.40%) |
Gross unrecognized tax benefits | $ 3,200 | ||
Gross unrecognized tax benefits which would affect the effective tax rate if recognized | 2,500 | ||
Norwegian | 2013 | Under appeal | |||
Income Taxes | |||
Additional income tax expense | $ 16,600 | kr 141.3 |
Subsequent Event (Details)
Subsequent Event (Details) $ in Millions | Apr. 22, 2021USD ($) |
Subsequent event | Skyworks Solutions, Inc. | |
Subsequent Event [Line Items] | |
Cash consideration | $ 2,750 |